Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
02 Janeiro 2024 - 6:52PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
|
FORM
12b-25 |
SEC FILE NUMBER
001-39341 |
|
|
|
|
|
|
|
CUSIP NUMBER
67054R 104
67054R 112 |
|
NOTIFICATION OF LATE
FILING |
|
(Check
One): ☒ Form
10-K ☐ Form 20-F ☐ Form
11-K ☐ Form
10-Q ☐ Form N-SAR ☐ Form
N-CAR
For Period Ended: September
30, 2023
☐ Transition
Report on Form 10-K
☐ Transition
Report on Form 20-F
☐ Transition
Report on Form 11-K
☐ Transition
Report on Form 10-Q
☐ Transition
Report on Form N-SAR
For the Transition Period Ended: ________________________________________________________
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion
of the filing checked above, identify the item(s) to which the notification relates:
PART I - REGISTRANT
INFORMATION
Nukkleus Inc.
Full name of registrant
Former name if applicable
525 Washington Blvd.
Address of principal executive office
Jersey City, New Jersey 07310
City, state and zip code
PART II - RULE
12b-25 (b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25
(b), the following should be completed. (Check box if appropriate.)
|
|
(a) |
The reasons described in reasonable
detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
☒ |
|
(b) |
The subject annual report,
semi-annual report, transition report on Form 10-K, 20-F, 11-K, Form N-SAR, Form N-CSR, or portion thereof, will be filed on or before
the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form
10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following
the prescribed due date; and |
|
|
(c) |
The accountant’s statement
or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III
NARRATIVE
State
below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed
within the prescribed time period.
The
Company’s Annual Report on Form 10-K for the annual period ended September 30, 2023 cannot be filed within the prescribed time
period because the Company’s auditor was recently acquired and requires additional time to review certain information required
to be included in the Form 10-K. The Company’s Annual Report on Form 10-K will be filed on or before the 15th calendar
day following the prescribed due date.
Part
IV
Other
Information
(1) Name and telephone number of person
to contact in regard to this notification
Emil
Assentato, CEO |
|
(212) |
|
791-4663 |
(Name) |
|
(Area Code) |
|
(Telephone Number) |
(2) Have all other periodic reports
required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer
is no, identify report(s).
☒
Yes ☐ No
(3) Is it anticipated that any significant
change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to
be included in the subject report or portion thereof?
☐
Yes ☒ No
If so: attach an explanation of the
anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results
cannot be made.
Nukkleus Inc.
Name of Registrant
as Specified in Charter.
Has caused this notification to be signed
on its behalf by the undersigned thereunto duly authorized.
Date: January 2,
2024 |
By: |
/s/
Emil Assentato |
|
|
Emil Assentato |
|
|
Chief Executive Officer |
3
Nukkleus (NASDAQ:NUKK)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Nukkleus (NASDAQ:NUKK)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025